Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Roylance

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Research|April 6, 2006
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancersMichelle Gaasenbeek, Kimberley Howarth, Andrew J Rowan, et al.
Oncogene|May 17, 2006
A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGHR Roylance, P Gorman, T Papior, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2002
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APCO M Sieber, K Heinimann, P Gorman, et al.
Nature Medicine|September 2, 1999
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesisH Lamlum, M Ilyas, A Rowan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2015
Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trialM Jamal-Hanjani, R A'Hern, N J Birkbak, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 14, 2022
A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast CancerA Lerner, K Keshwani, A Okines, et al.
The Journal of Pathology|November 5, 2003
MSI-low, a real phenomenon which varies in frequency among cancer typesSarah E R Halford, Elinor J Sawyer, Maryou B Lambros, et al.
Nature Genetics|February 28, 2002
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerIan P M Tomlinson, N Afrina Alam, Andrew J Rowan, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Nature|April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancerJean E Abraham, Karen Pinilla, Alimu Dayimu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Research|April 6, 2006
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancersMichelle Gaasenbeek, Kimberley Howarth, Andrew J Rowan, et al.
Oncogene|May 17, 2006
A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGHR Roylance, P Gorman, T Papior, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2002
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APCO M Sieber, K Heinimann, P Gorman, et al.
Nature Medicine|September 2, 1999
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesisH Lamlum, M Ilyas, A Rowan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2015
Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trialM Jamal-Hanjani, R A'Hern, N J Birkbak, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 14, 2022
A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast CancerA Lerner, K Keshwani, A Okines, et al.
The Journal of Pathology|November 5, 2003
MSI-low, a real phenomenon which varies in frequency among cancer typesSarah E R Halford, Elinor J Sawyer, Maryou B Lambros, et al.
Nature Genetics|February 28, 2002
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerIan P M Tomlinson, N Afrina Alam, Andrew J Rowan, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
Nature|April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancerJean E Abraham, Karen Pinilla, Alimu Dayimu, et al.
Pageof 4